Concourse Financial Group Securities, Inc. Tiziana Life Sciences LTD Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q1 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding TLSA
# of Institutions
35Shares Held
3.04MCall Options Held
24KPut Options Held
800-
Dauntless Investment Group, LLC Commerce Township, MI1.74MShares$2.49 Million2.2% of portfolio
-
Jane Street Group, LLC New York, NY168KShares$239,5850.0% of portfolio
-
Omers Administration Corp Toronto, A6145KShares$207,2070.0% of portfolio
-
Morgan Stanley New York, NY139KShares$198,8150.0% of portfolio
-
Hsbc Holdings PLC London, X0105KShares$150,6710.0% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $146M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...